Clinical Trial Update: A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating the delivery of dapivirine from a matrix vaginal ring for HIV prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED